ClinGen's GenomeConnect registry enables patient-centered data sharing.

Savatt JM1, Azzariti DR2, Faucett WA1,3, Harrison S2,4, Hart J5, Kattman B5, Landrum MJ5, Ledbetter DH1,3, Miller VR6, Palen E1, Rehm HL2,4,7,8, Rhode J6, Turner S1,9, Vidal JA6, Wain KE1, Riggs ER1, Martin CL1,3.

Author information

Abstract

GenomeConnect, the NIH-funded Clinical Genome Resource (ClinGen) patient registry, engages patients in data sharing to support the goal of creating a genomic knowledge base to inform clinical care and research. Participant self-reported health information and genomic variants from genetic testing reports are curated and shared with public databases, such as ClinVar. There are four primary benefits of GenomeConnect: (1) sharing novel genomic data-47.9% of variants were new to ClinVar, highlighting patients as a genomic data source; (2) contributing additional phenotypic information-of the 52.1% of variants already in ClinVar, GenomeConnect provided enhanced case-level data; (3) providing a way for patients to receive variant classification updates if the reporting laboratory submits to ClinVar-97.3% of responding participants opted to receive such information and 13 updates have been identified; and (4) supporting connections with others, including other participants, clinicians, and researchers to enable the exchange of information and support-60.4% of participants have opted to partake in participant matching. Moving forward, ClinGen plans to increase patient-centric data sharing by partnering with other existing patient groups. By engaging patients, more information is contributed to the public knowledge base, benefiting both patients and the genomics community.